- TRADE NAME: Naropin (AstraZeneca)
- INDICATIONS: Surgical anesthesia, acute pain management
- CLASS: Anesthetic; local
- HALF-LIFE: 1.1–2.5 hours after intravascular administration; 3.2–5.2 hours after epidural administration
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Adenosine, Aminophylline, Amiodarone, Ciprofloxacin, Dronedarone, Fluvoxamine, Imipramine, Ketoconazole
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Page last updated 07/31/2023
